Katerina Chatzi net worth
Quick answer
Katerina Chatzi's estimated net worth is $625K (range $438K – $938K) as of 2026. Katerina Chatzi is Founder at Promakhos Therapeutics. Promakhos Therapeutics valuation.
Katerina Chatzi is Founder at Promakhos Therapeutics (YC S21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 2
- Website: https://www.promakhos.com/
Who is Katerina Chatzi?
Katerina Chatzi is a co-founder of Promakhos Therapeutics, which was part of Y Combinator's Summer 2021 cohort.
Highlights:
- Degree in Biology from Stanford University
- Experience in biotech startups
- Involved in drug development
About Promakhos Therapeutics
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
FAQ: Katerina Chatzi net worth and Promakhos Therapeutics valuation
What is Katerina Chatzi's net worth?
Katerina Chatzi's estimated net worth is $625K (range $438K – $938K) as of 2026. Katerina Chatzi is Founder at Promakhos Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Promakhos Therapeutics valuation?
Promakhos Therapeutics's estimated valuation on Entrepreneurial Check is $1.25M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Katerina Chatzi's role?
Katerina Chatzi is Founder at Promakhos Therapeutics, a Y Combinator-backed startup (batch S21).